CPC C07D 253/075 (2013.01) [A61K 9/0019 (2013.01); A61K 9/0053 (2013.01); A61K 31/135 (2013.01); A61K 31/415 (2013.01); A61K 31/475 (2013.01); A61K 31/53 (2013.01); A61K 45/06 (2013.01); A61P 35/00 (2018.01); A61K 31/122 (2013.01); A61K 31/337 (2013.01); A61K 31/4184 (2013.01); A61K 31/437 (2013.01); A61K 33/243 (2019.01)] | 5 Claims |
1. A pharmaceutical composition comprising:
a small molecule prolactin receptor (PRLR) inhibitor according to Formula II or a pharmaceutical salt thereof; and
at least one pharmaceutically acceptable carrier,
wherein Formula II is structurally depicted as:
and wherein:
R1 is selected from —CY3, linear or cyclic alkyl, halogen, cycloalkyl, heterocycloalkyl, alkenyl, alkynyl, aryl, heteroaryl, and H;
X is selected from —NH2, halogen, —OH, —SH, —NO2, —COOH, —SO3H, and —SO2NH2;
n is 0 or an integer between 1 and 10; and
each Y is independently H or halogen selected from Cl, Br, F, and I.
|